Triple‐Kill Nano‐Disruptor Integrating Ion Interference, Metabolic Inhibition, and Immune Activation for Augmented Apoptosis and Pyroptosis‐Mediated Immunotherapy
Ion-overload-mediated pyroptosis can enhance cytotoxic T-cell infiltration and systemic immunity, presenting a promising strategy to strengthen immunotherapy efficacy. However, the low frequency of pro-inflammatory immune cells and the immunosuppressive tumor network pose substantial challenges to achieving potent immunogenic cell death. This study designs a multiphase phase-transition nano-disruptor (V-MoS<sub>2</sub>&CaF<sub>2</sub>@HA), inspired by ionic interference and metabolic inhibition, to target multiple immunosuppressive mechanisms in tumors. Vanadium-doping engineering induces the coexistence of the 2H (semiconducting) and 1T (metallic) phases, maximizing the ability of piezocatalysts to enhance charge-carrier mobility. Critically, V-MoS<sub>2</sub> with its ultrathin, asymmetrical layered architecture, reinforces the piezoelectric response by promoting band bending and charge-carrier separation, thereby establishing favorable conditions for efficient electron-hole separation and reactive oxygen species generation. Concurrently, calcium-ion self-amplifying leakage and hydrogen sulfide liberation collectively create an "ion-interference-metabolic-hijacking" effect that induces oxidative stress, amplifies innate immune cGAS-STING pathway activation, and triggers a pyroptosis-apoptosis cross-death effect and immune activation. Thus, the study offers a straightforward strategy to achieve antitumor immunity through STING pathway activation and provides a new avenue to robustly activate immunogenic cell death for tumor treatment.
Authors
- Wubin Lv
- Yuxuan Zhao (ORCID: https://orcid.org/0000-0001-7506-1703)
- Ruizheng Liang (ORCID: https://orcid.org/0000-0002-3930-9625)
- Piaoping Yang (ORCID: https://orcid.org/0000-0002-9555-1803)
- Shili Gai (ORCID: https://orcid.org/0000-0001-9653-4944)
- Shiyu Zhang (ORCID: https://orcid.org/0000-0003-2474-7451)
- Siyi Li (ORCID: https://orcid.org/0000-0003-3365-6818)
- Lei Zhong (ORCID: https://orcid.org/0000-0002-0208-1823)
- Xiucheng Zhao
- He Ding (ORCID: https://orcid.org/0000-0002-2371-5119)
Institutions
- Harbin Engineering University (CN)
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
- Beijing University of Chemical Technology (CN)
Publication Details
- Journal
- Advanced Materials
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1002/adma.202516688
- Citations
- 2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.35